BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3383723)

  • 1. Development of phenobarbital glucosidation in the human neonate.
    Bhargava VO; Garrettson LK
    Dev Pharmacol Ther; 1988; 11(1):8-13. PubMed ID: 3383723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic fate of phenobarbital. A quantitative study of p-hydroxyphenobarbital elimination in man.
    Whyte MP; Dekaban AS
    Drug Metab Dispos; 1977; 5(1):63-70. PubMed ID: 13977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sample stacking microemulsion electrokinetic capillary chromatography induced by reverse migrating pseudostationary phase for the quantification of phenobarbital and its p-hydroxyphenobarbital metabolite in rat urine.
    Kadi A; Hefnawy M; Julkhuf S; Abounassif M; Mostafa G; Kassem MG; Attia S; Al-Ghamdi A
    Analyst; 2011 Jul; 136(13):2858-65. PubMed ID: 21607283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenobarbital disposition in the neonate.
    Garrettson LK
    Addict Dis; 1975; 2(1-2):179-85. PubMed ID: 1163361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of diphenylhydantoin and its main hydroxylated metabolite on the pharmacokinetics and the urinary and biliary excretion of phenobarbital and its p-hydroxy metabolite.
    Sarhan F; Engasser JM; Batt AM; Magdalou J; Siest G
    Eur J Drug Metab Pharmacokinet; 1981; 6(2):99-108. PubMed ID: 7306277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of phenobarbital following single and repeated doses.
    Viswanathan CT; Booker HE; Welling PG
    J Clin Pharmacol; 1979; 19(5-6):282-9. PubMed ID: 469023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The metabolism and excretion of enzyme-inducing doses of phenobarbital by rats with bile fistulas.
    Levin SS; Vars HM; Schleyer H; Cooper DY
    Xenobiotica; 1986 Mar; 16(3):213-24. PubMed ID: 3705618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Pharmacology of Phenobarbital in Neonates: Effects, Metabolism and Pharmacokinetics.
    Pacifici GM
    Curr Pediatr Rev; 2016; 12(1):48-54. PubMed ID: 26496779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of liver disease in man on the disposition of phenobarbital.
    Alvin J; McHorse T; Hoyumpa A; Bush MT; Schenker S
    J Pharmacol Exp Ther; 1975 Jan; 192(1):224-35. PubMed ID: 235636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of activated charcoal to reduce elevated serum phenobarbital concentration in a neonate.
    Veerman M; Espejo MG; Christopher MA; Knight M
    J Toxicol Clin Toxicol; 1991; 29(1):53-8. PubMed ID: 2005666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of phenobarbital, p-hydroxyphenobarbital and phenobarbital-N-glucoside in urine by gas chromatography chemical ionization mass spectrometry.
    Tang BK; Yilmaz B; Kalow W
    Biomed Mass Spectrom; 1984 Sep; 11(9):462-5. PubMed ID: 6509155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic fate of phenobarbital in man. N-Glucoside formation.
    Tang BK; Kalow W; Grey AA
    Drug Metab Dispos; 1979; 7(5):315-8. PubMed ID: 40773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LC determination of the diastereomers of 1-(beta-D-glucopyranosyl)phenobarbital in human urine.
    Soine WH; Soine PJ; England TM; Welty DF; Wood JH
    J Pharm Biomed Anal; 1990; 8(4):365-72. PubMed ID: 2100211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism, distribution and anticonvulsant properties of N,N'- dimethoxymethyl-phenobarbital in the rat.
    Baumel IP; Gallagher BB; Dimicco J; Dionne R
    J Pharmacol Exp Ther; 1976 Jan; 196(1):180-7. PubMed ID: 1246009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Individualizing phenobarbital dosing in neonates.
    Gilman ME; Toback JW; Gal P; Erkan NV
    Clin Pharm; 1983; 2(3):258-62. PubMed ID: 6883954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenobarbital and diphenylhydantoin levels in neonates with seizures.
    Painter MJ; Pippenger C; MacDonald H; Pitlick W
    J Pediatr; 1978 Feb; 92(2):315-9. PubMed ID: 621616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intravenous injection of phenobarbital for benign convulsions with mild gastroenteritis].
    Takami Y; Ban H
    No To Hattatsu; 2012 Nov; 44(6):461-4. PubMed ID: 23240527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Phenobarbital in newborn infants. Overview].
    Staudt F
    Monatsschr Kinderheilkd; 1984 Apr; 132(4):194-202. PubMed ID: 6374432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereochemical characterization of the diastereomers of the phenobarbital N-beta-D-glucose conjugate excreted in human urine.
    Soine WH; Soine PJ; Mongrain SE; England TM
    Pharm Res; 1990 Apr; 7(4):402-6. PubMed ID: 2362916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary excretion of phenobarbitone and its metabolites in chronically treated patients.
    Bernus I; Dickinson RG; Hooper WD; Eadie MJ
    Eur J Clin Pharmacol; 1994; 46(5):473-5. PubMed ID: 7957546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.